UNSPSC 51282106: Clometocillin

This classification denotes a penicillin antibiotic with the molecular formula C17H18Cl2N2O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YI8LL014GF, chemically known as (3,4-dichloro-alpha-methoxybenzyl)penicillin but generally known as clometocillin, which bears US NIH Compound Identifier 71807. European Medicines Agency schedules Clometocillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06721MIG.

UNSPSC 51282106 Clometocillin is a Commodity code with negligible recent state and local procurement activity. The nominal scope of this code—a specific antibiotic pharmaceutical—does not align with the work actually being solicited under it. The most recent opportunities tagged to this code cover naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, emergency medical and first aid supplies for fire departments, and generic multi-source pharmaceuticals and OTC products through cooperative purchasing. These solicitations diverge substantially from clometocillin's antibiotic indication and suggest either misclassification of opportunities or very limited use of this specific pharmaceutical in state and local health procurement.

The issuing bodies include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), municipal emergency services (City of Tampa Fire Department), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving multiple states including Oregon). Geographic activity appears concentrated in Florida, Texas, Minnesota, and Oregon, with the most recent and substantive opportunities posted between January and June 2026. Representative solicitations include Seminole County's IFB for 1,900 units of naloxone and 800 drug deactivation systems annually (due July 26, 2023), the City of Tampa's IFB for 169 line items of medical and first aid supplies estimated at $700,000 with a five percent small local business enterprise discount (due March 13, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products (due March 26, 2026). The code shows little activity specific to clometocillin procurement and does not support a pursue strategy based on recent sourcing patterns.